Schedule 13G ownership disclosure
Orexigen Therapeutics, Inc.
Security class unavailable · CUSIP: 686164104
Event date: 2015-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.1700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-15-037316
- Form type
- SC 13G
- Filer
- BAUPOST GROUP LLC/MA
- CIK
- CIK 1061768
- Filed
- Oct 09, 2015
- Reporting period
- Sep 30, 2015
- Description
- Schedule 13G beneficial ownership